Latest Articles

  • Overcoming barriers to hypertension control in African Americans
    Taiye Odedosu, MD, Antoinette Schoenthaler, EdD, Dorice L. Vieira, MLS, MPH, MA, Charles Agyemang, PhD and Gbenga Ogedegbe, MD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 46-56; DOI: https://doi.org/10.3949/ccjm.79a.11068
  • Diffuse reticulonodular infiltrates
    Maria Giselle S. Velez, MD, FACP and Vicente Jose M. Velez, MD, FACP
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 16-17; DOI: https://doi.org/10.3949/ccjm.78a.11009
  • Managing community-acquired pneumonia during flu season
    Sarah Haessler, MD and Jennifer J. Schimmel, MD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 67-78; DOI: https://doi.org/10.3949/ccjm.79a.11108
  • Skin and soft-tissue infections: Classifying and treating a spectrum
    Sabitha Rajan, MD, MSc, FHM
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 57-66; DOI: https://doi.org/10.3949/ccjm.79a.11044
  • Cytomegalovirus colitis
    Jana G. Hashash, MD, Marwan Refaat, MD, Abdulrahman Abdulbaki, MD, Elie G. Aoun, MD and Leonard Baidoo, MD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 12-13; DOI: https://doi.org/10.3949/ccjm.78a.11028
  • Correction
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 78; DOI: https://doi.org/10.3949/ccjm.79c.01001
  • Should target natriuretic peptide levels be used for outpatient management of chronic heart failure?
    Ahmed Ibrahim, MD, Motaz Baibars, MD, M. Chadi Alraies, MD, FACP and Guilherme H. Oliveira, MD
    Cleveland Clinic Journal of Medicine January 2012, 79 (1) 22-25; DOI: https://doi.org/10.3949/ccjm.79a.11066
  • Essential tremor: Choosing the right management plan for your patient
    Essential tremor: Choosing the right management plan for your patient
    Hesham Abboud, MD, Anwar Ahmed, MD and Hubert H. Fernandez, MD
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 821-828; DOI: https://doi.org/10.3949/ccjm.78a.10178

    Successful management entails excluding secondary causes, carefully selecting drug therapy, and, in severe resistant or atypical cases, referring to a specialist.

  • Dabigatran (October 2011)
    Van Smith, MD, FACP
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 787; DOI: https://doi.org/10.3949/ccjm.78c.12001

    Readers comment on negative U waves (August 2011) and on dabigatran (October 2011).

  • Bioidentical hormone therapy: Clarifying the misconceptions
    Lynn Pattimakiel, MD, NCMP and Holly L. Thacker, MD, FACP, NCMP
    Cleveland Clinic Journal of Medicine December 2011, 78 (12) 829-836; DOI: https://doi.org/10.3949/ccjm.78a.10114

    Many women are turning to bioidentical hormone therapy on the basis of misconceptions, which we hope to clarify.

Pages